Barclays PLC Care Dx, Inc. Transaction History

Barclays PLC

$357 Billion
Q4 2024

A detailed history of Barclays PLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Barclays PLC holds 112,076 shares of CDNA stock, worth $1.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

112,076

Previous 98,505 13.78%

Holding current value

$1.99 Million

Previous $3.08 Million 22.02%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$20.4 - $32.2 $276,848 - $436,986	13,571 Added 13.78%	112,076 $2.4 Million
Q3 2024 Nov 15, 2024	BUY	$14.41 - $33.99 $785,085 - $1.85 Million	54,482 Added 123.76%	98,505 $3.08 Million
Q2 2024 Aug 14, 2024	SELL	$7.56 - $16.15 $112,621 - $240,586	-14,897 Reduced 25.28%	44,023 $683,000
Q1 2024 May 15, 2024	SELL	$7.96 - $12.37 $684,735 - $1.06 Million	-86,022 Reduced 59.35%	58,920 $624,000
Q4 2023 Feb 15, 2024	SELL	$4.9 - $12.86 $89,292 - $234,347	-18,223 Reduced 11.17%	144,942 $1.74 Million
Q3 2023 Nov 07, 2023	SELL	$7.0 - $11.26 $40,971 - $65,904	-5,853 Reduced 3.46%	163,165 $1.14 Million
Q2 2023 Aug 03, 2023	BUY	$7.61 - $9.46 $56,055 - $69,682	7,366 Added 4.56%	169,018 $1.44 Million
Q1 2023 May 04, 2023	SELL	$8.83 - $17.61 $824,121 - $1.64 Million	-93,332 Reduced 36.6%	161,652 $1.48 Million
Q4 2022 Feb 13, 2023	BUY	$10.88 - $20.05 $749,632 - $1.38 Million	68,900 Added 37.03%	254,984 $2.91 Million
Q3 2022 Nov 03, 2022	BUY	$16.06 - $26.39 $2.64 Million - $4.34 Million	164,430 Added 759.35%	186,084 $3.17 Million
Q2 2022 Aug 12, 2022	SELL	$20.49 - $39.72 $86,242 - $167,181	-4,209 Reduced 16.27%	21,654 $466,000
Q1 2022 May 16, 2022	SELL	$28.19 - $46.6 $1 Million - $1.66 Million	-35,548 Reduced 57.89%	25,863 $957,000
Q4 2021 Feb 14, 2022	BUY	$41.2 - $73.6 $1.2 Million - $2.14 Million	29,135 Added 90.27%	61,411 $2.79 Million
Q3 2021 Nov 09, 2021	BUY	$59.15 - $91.99 $707,434 - $1.1 Million	11,960 Added 58.87%	32,276 $2.05 Million
Q2 2021 Aug 13, 2021	SELL	$63.02 - $95.11 $3.59 Million - $5.42 Million	-56,992 Reduced 73.72%	20,316 $1.86 Million
Q1 2021 May 13, 2021	BUY	$57.62 - $95.6 $3.53 Million - $5.85 Million	61,242 Added 381.19%	77,308 $5.26 Million
Q4 2020 Feb 11, 2021	SELL	$41.43 - $77.09 $243,235 - $452,595	-5,871 Reduced 26.76%	16,066 $1.16 Million
Q3 2020 Nov 12, 2020	SELL	$30.88 - $37.94 $3.96 Million - $4.86 Million	-128,162 Reduced 85.38%	21,937 $832,000
Q2 2020 Aug 12, 2020	BUY	$18.95 - $35.43 $771,265 - $1.44 Million	40,700 Added 37.2%	150,099 $5.32 Million
Q1 2020 May 13, 2020	BUY	$13.94 - $28.25 $910,351 - $1.84 Million	65,305 Added 148.1%	109,399 $2.39 Million
Q4 2019 Feb 10, 2020	BUY	$19.24 - $28.41 $421,875 - $622,946	21,927 Added 98.92%	44,094 $951,000
Q3 2019 Nov 14, 2019	SELL	$20.03 - $40.08 $149,043 - $298,235	-7,441 Reduced 25.13%	22,167 $501,000
Q2 2019 Aug 14, 2019	SELL	$25.78 - $39.77 $253,211 - $390,620	-9,822 Reduced 24.91%	29,608 $1.07 Million
Q1 2019 May 15, 2019	BUY	$22.09 - $39.21 $818,257 - $1.45 Million	37,042 Added 1551.17%	39,430 $1.24 Million
Q4 2018 Feb 14, 2019	SELL	$19.89 - $30.02 $432,030 - $652,064	-21,721 Reduced 90.09%	2,388 $60,000
Q3 2018 Nov 14, 2018	BUY	$12.1 - $28.85 $256,665 - $611,966	21,212 Added 732.21%	24,109 $696,000
Q2 2018 Aug 14, 2018	BUY	$7.93 - $15.79 $11,062 - $22,027	1,395 Added 92.88%	2,897 $35,000
Q1 2018 May 15, 2018	SELL	$5.18 - $7.97 $3,905 - $6,009	-754 Reduced 33.42%	1,502 $12,000
Q4 2017 Feb 14, 2018	BUY	$3.98 - $7.37 $8,978 - $16,626	2,256	2,256 $17,000

Others Institutions Holding CDNA

# of Institutions

222

Shares Held

53.7M

Call Options Held

53.5K

Put Options Held

23.9K

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $950M
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account